The promising results of the diagnostic and endoradiotherapeutic approaches which have been successfully applied into the clinical setting using PSMA-based radiotracers rendered several research groups to make use of suitable PSMA-based radiotracers for other therapeutic strategies, such as the image-guided surgery of prostate cancer lesions. The gene discussed is FOLH1; the disease is Familial prostate cancer.